The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer

The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer

Bibliographic Details
Main Authors:	Yan Liu, Yuzhi Wang, Shiyi Yu, Yehui Zhou, Xinxing Ma, Qian Su, Li An, Feifei Wang, Aihua Shi, Jingzhong Zhang, Liming Chen
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2019-03-01
Series:	Cellular Physiology and Biochemistry
Online Access:	https://www.cellphysiolbiochem.com/Articles/000027/

Similar Items

Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple‐Negative Breast Cancer Tumor Growth
by: Yan Liu, et al.
Published: (2021-02-01)

Drug Repurposing for Triple-Negative Breast Cancer
by: Marta Ávalos-Moreno, et al.
Published: (2020-10-01)

Investigational Drug Treatments for Triple-Negative Breast Cancer
by: Christos Damaskos, et al.
Published: (2021-07-01)

Novel antibody–drug conjugates for triple negative breast cancer
by: Aiko Nagayama, et al.
Published: (2020-05-01)

Approach to the Triple Negative Breast Cancer in New Drugs Area
by: Mehrzad Mirzania
Published: (2016-04-01)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
by: Élia Cipriano, et al.
Published: (2021-03-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Triple-negative breast cancer: understanding Wnt signaling in drug resistance
by: Parnaz Merikhian, et al.
Published: (2021-08-01)

Metabolic reprogramming in triple-negative breast cancer
by: Zhanyu Wang, et al.
Published: (2020-02-01)

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers
by: Yiduo Liu, et al.
Published: (2021-05-01)

Metabolic Reprogramming in Triple-Negative Breast Cancer
by: Xiangyu Sun, et al.
Published: (2020-03-01)

Immunotherapeutic interventions of Triple Negative Breast Cancer
by: Zehuan Li, et al.
Published: (2018-05-01)

Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer
by: Xinxing Wang, et al.
Published: (2021-04-01)

The Proteomic Landscape of Triple-Negative Breast Cancer
by: Robert T. Lawrence, et al.
Published: (2015-05-01)

The Proteomic Landscape of Triple-Negative Breast Cancer
by: Robert T. Lawrence, et al.
Published: (2015-04-01)

Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors
by: Imke H. Bartelink, et al.
Published: (2017-09-01)

Role of SMC1 in overcoming drug resistance in triple negative breast cancer.
by: Sushma Yadav, et al.
Published: (2013-01-01)

Iodide Analogs of Arsenoplatins—Potential Drug Candidates for Triple Negative Breast Cancers
by: Ðenana Miodragović, et al.
Published: (2021-09-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Therapeutic landscape in mutational triple negative breast cancer
by: Yaqin Shi, et al.
Published: (2018-07-01)

Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics
by: Nan Wang, et al.
Published: (2021-08-01)

The expression of APE1 in triple-negative breast cancer and its effect on drug sensitivity of olaparib
by: Tianran Chen, et al.
Published: (2017-10-01)

Oncolytic viruses for triple negative breast cancer and beyond
by: Shengye Jin, et al.
Published: (2021-09-01)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
by: Swanner J, et al.
Published: (2015-06-01)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
by: Jiande Wu, et al.
Published: (2020-06-01)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
by: Homero Gonçalves, et al.
Published: (2018-07-01)

Investigating the Role of Galectin-8 in Drug Resistance Triple-Negative Breast Cancer Cells
by: Chi-Chun Pang, et al.
Published: (2018)

Clinical Characteristics in Patients with Triple Negative Breast Cancer
by: Janet Yeh, et al.
Published: (2017-01-01)

MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
by: Mao Ouyang, et al.
Published: (2014-01-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
by: Ling Wang, et al.
Published: (2018-07-01)

Estrogen Actions in Triple-Negative Breast Cancer
by: Oliver Treeck, et al.
Published: (2020-10-01)

Management Options in Triple-Negative Breast Cancer
by: Christina A. Minami, et al.
Published: (2011-01-01)

Management Options in Triple-Negative Breast Cancer
by: Christina A. Minami, et al.
Published: (2011-07-01)

Clinicopathological Study of Triple Negative Breast Cancers
by: Gunadala Ishitha, et al.
Published: (2016-09-01)

Clinicopathological Features of Triple Negative Breast Carcinoma
by: Gowry Maram Reddy, et al.
Published: (2017-01-01)

Immunohistochemical Differentiation of Triple Negative Breast Cancer
by: Nikola Lesar, et al.
Published: (2016-01-01)

MicroRNAs and Triple Negative Breast Cancer
by: Marilena V. Iorio, et al.
Published: (2013-11-01)

Targeting EGFR in Triple Negative Breast Cancer
by: Naoto T. Ueno, Dongwei Zhang
Published: (2011-01-01)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer
by: Domenico Ribatti, et al.
Published: (2016-10-01)